Leronlimab (PRO 140) Combined With Carboplatin in Patients With Cytokine Chemokine Receptor 5 Positive (CCR5+) mTNBC

Clinical trial NCT03838367 · TERMINATED

Trial details

NCT number: NCT03838367
Sponsor: CytoDyn, Inc.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Triple Negative Breast Neoplasms

Start date: 2019-04-22
Primary completion: 2022-07-15
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.